background Layer 1

CUNY Graduate Center has developed an innovative model of artificial intelligence

The world of science remains conservative and focuses on comprehensive usage of AI for the benefit of our health. A research team at the CUNY Graduate Center has developed a novel AI model to improve the accuracy and reduce the time and cost of the drug development process. The model, called CODE-AE, screens novel drug compounds to accurately predict efficacy in humans.
Tests, undergone on over 9,000 patients, show its high level of prediction of personalized drugs that could better treat conditions of individual patients. 

In today's era of digitalisation, businesses in all sectors are facing new challenges. Competition is intensifying, customers are becoming more demanding and technology is evolving at breakneck speed. To remain competitive, businesses need to change. And one of the key steps along the way may be migrating to the cloud.

The right choice of a business partner is one of the main tasks of any business. The quality of goods or services that the company receives, as well as its reputation, depend on the reliability of the supplier. To make the process transparent and convenient, scoring models for assessing reliability come to the rescue.

Summer is coming to an end, but life in the analytics field is bustling. New vendor announcements, promising projects, and the pervasive penetration of AI into all areas of our lives are paving the way for the upcoming business season.

Maksim Karankevich, Director of Data and Digital Transformation, Ultramar, in his presentation shared his experience of implementing a cellular-based industrial radio network.

We use cookies for analytical purposes and to deliver you the best experience with our website. Continuing to the site, you agree to the Cookie Policy.